Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05RQB
|
||||
Former ID |
DNC000238
|
||||
Drug Name |
Aphidicolin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Discontinued in Phase 1 | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C20H34O4
|
||||
Canonical SMILES |
CC12CCC(C(C1CCC3C24CCC(C(C3)C4)(CO)O)(C)CO)O
|
||||
InChI |
1S/C20H34O4/c1-17(11-21)15-4-3-13-9-14-10-19(13,7-8-20(14,24)12-22)18(15,2)6-5-16(17)23/h13-16,21-24H,3-12H2,1-2H3/t13?,14?,15?,16-,17+,18+,19?,20+/m1/s1
|
||||
InChIKey |
NOFOAYPPHIUXJR-NPNXGXLRSA-N
|
||||
CAS Number |
CAS 38966-21-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | DNA polymerase (HSV-2) | Target Info | Inhibitor | [2], [3] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002516) | ||||
REF 2 | Proteasome regulation of ULBP1 transcription. J Immunol. 2009 May 15;182(10):6600-9. | ||||
REF 3 | Characterization of an aphidicolin-resistant mutant of herpes simplex virus type 2 which induces an altered viral DNA polymerase. Virology. 1984 May;135(1):87-96. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.